Valganciclovir (valganciclovir) is a drug produced in which country? Drug source and production country

Valganciclovir (Valganciclovir) is an antiviral drug mainly used to prevent and treat infections caused by cytomegalovirus (CMV), which is especially common in organ transplant patients and people with low immune function. This drug is the prodrug of ganciclovir (Ganciclovir). After intestinal absorption, it is quickly converted into the active ingredient ganciclovir in the body, thereby exerting antiviral effects. The original drug of Vancevi was developed by the Swiss pharmaceutical company Roche (Roche) and was initially approved for marketing in countries and regions such as the United States and Europe.

Internationally, as an important antiviral treatment, Vancevir has been approved by drug regulatory agencies in many countries, including the United StatesFDA and EuropeEMA, and is widely used in clinical treatment. Especially in the context of immunosuppressive treatment such as kidney transplantation and heart transplantation, valganciclovir is considered to be one of the standard drugs for preventing cytomegalovirus infection. Its original brand drug "Valcyte" is produced by the Swiss company Roche and supplied to the global market.

In recent years, as the patent period of Vancevi has expired, some countries such as India have also begun to produce generic versions of its drugs. These drugs are highly consistent with the original drugs in terms of ingredients and bioequivalence, and have been approved for marketing by their national drug regulatory agencies. Globally, patients can choose original drugs or generic drugs based on their economic status. Especially in areas with limited resources or not covered by medical insurance, generic drugs produced in India or Bangladesh have become a viable option for many patients.

In general, Vansavi was originally developed in Switzerland and first launched in European and American countries, and was subsequently widely promoted around the world. At present, in addition to Switzerland, the country of origin, many countries including the United States, India, China, etc. also have repackaged, sold or imitated versions. When purchasing drugs, patients should reasonably choose original drugs or generic drugs based on doctor's advice, combined with their own health status, financial ability and drug purchasing channels, and ensure that the sources are regular and safe.

Reference materials:https://go.drugbank.com/drugs/DB01610